Cellectis Acquires Exclusive License to Tal Effector Patents From University of Minnesota PARIS, Jan. 20, 2011 (GLOBE NEWSWIRE) -- Cellectis (Alternext: ALCLS), the French genome engineering specialist, has announced today that it has signed an exclusive license agreement with the...